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Abstract
 
Asthma is thought to result from an abnormal expansion of CD4 T cells reactive with airborne
allergens, and pathology is controlled by several cytokines of the T helper type 2 (Th2) family.
The exact molecules which are involved in generating allergen-reactive T cells are not clear.
Studies with blocking reagents or knockout animals have shown that the CD28/B7 interaction
partially controls development of allergic asthma in mouse models, but may not be the sole
molecule involved. In this report, we have investigated the role of the tumor necrosis factor re-
ceptor family member OX40 in allergic inflammation using OX40-deficient mice. OX40 has
been shown to participate in regulating clonal expansion and memory development of CD4 T
cells and may synergize with CD28. Our studies demonstrate that OX40
 
2
 
/
 
2 
 
mice, primed with
the model allergen ovalbumin and challenged through the airways with aerosolized antigen, are
severely impaired in their ability to generate a Th2 response characterized by high levels of in-
terleukin (IL)-5, IL-4, and immunoglobulin E. Moreover, OX40
 
2
 
/
 
2
 
 mice exhibit diminished
lung inflammation, including an 80–90% reduction in eosinophilia and mucus production, less
goblet cell hyperplasia, and significantly attenuated airway hyperreactivity. These studies high-
light the potential importance of OX40 in development of allergic asthma and suggest that tar-
geting OX40 may prove useful therapeutically.
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Introduction
 
Asthma is a multifactorial disease characterized by chronic
inflammation in the lungs. The most common form, ex-
trinsic asthma, is believed to be driven by an immune re-
sponse to airborne allergens. The signature of the disease is
massive infiltration of the bronchial mucosa by several cell
types including lymphocytes, eosinophils, and mast cells,
and this is accompanied by a pronounced elevation in se-
rum IgE. Desquamation of the lung epithelium occurs,
along with goblet cell hyperplasia, thickening of the mu-
cosal layer, and mucus production within the bronchioles,
with the overall result being impeded airflow and airway
hyperreactivity (AHR).
Studies over the past few years, particularly in mice, have
established a critical role for the type 2 cytokines IL-4,
IL-5, IL-13, and recently IL-9, in the asthmatic response.
Studies of antibody blocking or in knockout mice have
clearly shown that IL-4 and IL-5 control many, although
not all, phases of asthma (1, 2), and recent data with recom-
binant IL-13 have also demonstrated that this cytokine can
reproduce much of the asthmatic reaction (3). IL-5 and
IL-4 may control eosinophilia and IgE (1, 2), and IL-13
and IL-9 may control mucus production and AHR (4, 5).
Although mast cells and eosinophils can produce type 2
cytokines, and are therefore potential contributors to the
inflammatory response in asthma, there is abundant clinical
and experimental evidence that initiation of the asthmatic
reaction is dependent on T cells, particularly those of the
CD4 subset. For example, depletion of CD4 cells from
mice can prevent AHR and eosinophilia (6), and Th2
clones or primary CD4 T cells secreting IL-4, IL-5, and
IL-13 can induce asthmatic symptoms if adoptively trans-
ferred into unimmunized recipients (4).
One strategy to control asthma is therefore to directly
block T cell activation by inhibiting recognition of antigen
and signaling through the T cell receptor. The usefulness of
anti-CD4 and pharmacological inhibitors that prevent T
cell signaling are being tested. The latter include cortico-
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steroids, cyclosporin A, FK506, and rapamycin. Another
strategy is to target costimulatory interactions that are es-
sential for full activation and effector function of T cells.
Two major interactions that are involved in the initial
stages of a T cell response are those between CD28/B7 and
CD40 ligand (CD40L)/CD40. Both have recently been
targeted in mouse models of asthma. The majority of stud-
ies have examined CD28/B7 and demonstrated that block-
ade of this pathway can reduce type 2 cytokines, IgE,
AHR, and eosinophilia (7–9). Contrasting data have been
published on the role of CD40L/CD40. In one study,
CD40 knockout mice were relatively normal in their abil-
ity to mount an eosinophil response and to develop AHR,
even though IgE levels were reduced (10), whereas in a
study of mice deficient in CD40L, a reduction in eosino-
phils and IL-4 was observed, but not IL-5 (11). Thus, liga-
tion of CD28 and perhaps CD40L appear to be involved in
development of the CD4 response that leads to asthma.
As well as molecules that regulate early phases of T cell
responses, additional costimulatory interactions have been
described between inducible molecules which may be cru-
cial for the development of a long-lasting T cell response
(for reviews, see references 12 and 13). In particular, signal-
ing through the TNFR family member OX40 (CD134) has
recently been shown to control clonal expansion, cytokine
production, and memory development of CD4 T cells in
several experimental situations involving either Th1 or Th2
cytokines (14–19). Whether OX40 is required for T cell re-
sponses in most disease situations is not known, nor
whether OX40 plays an obligatory role in development of
Th2 responses. Ligation of OX40 in vitro and in vivo can
enhance development of T cells secreting Th2 cytokines
(15, 19), and OX40 and OX40L knockout mice have been
shown to be defective in the weak Th2 responses that are
induced by priming with protein antigens (18, 19). In sup-
port of a role in Th2 responses in disease scenarios, blocking
OX40 suppressed the inflammatory response to 
 
Leishmania
major
 
 in BALB/c mice (20). However, in contrast to this,
there was no apparent requirement for OX40 in the Th2
response to the parasite 
 
Nippostrongylus brasiliensis
 
, suggest-
ing that there may not be an obligatory role for OX40 in
every situation where Th2 cytokines are produced (21).
In this report, we have investigated the role of OX40 in
development of allergic inflammation in a murine model of
asthma using mice deficient in OX40. The results clearly
demonstrate that much of the asthmatic Th2 response is de-
pendent on OX40/OX40L interactions including produc-
tion of high levels of IL-5, recruitment of large numbers of
eosinophils, and induction of IgE. Importantly, goblet cell
hyperplasia, mucus production, and AHR are all suppressed
in the absence of OX40, demonstrating that this molecule
plays a major role in development of the asthmatic reaction.
 
Materials and Methods
 
Induction of Allergic Airway Inflammation.
 
OX40
 
2
 
/
 
2
 
 mice (19,
21), backcrossed at least six times onto a C57BL/6 background,
were compared with wild-type (Wt) C57BL/6 mice obtained
 
from The Jackson Laboratory or produced as OX40
 
1
 
/
 
1
 
 littermates
from crossing heterozygous knockouts. Groups of mice were sen-
sitized by intraperitoneal injection of 20 
 
m
 
g OVA protein (chicken
egg albumin; Sigma-Aldrich) and 2 mg aluminum hydroxide in
PBS. After 4 wk, challenge doses of OVA were given through the
airways by subjecting mice for 30 min to 10 ml of a solution of 5
mg/ml OVA induced into aerosol form in a Plexiglas chamber
with a nebulizer. The challenge was performed once a day for four
consecutive days and then the mice were assessed for allergic in-
flammation of the lungs 1–3 h after the last aerosol exposure.
 
Measurement of AHR.
 
Responsiveness to 
 
b
 
-methacholine
was assessed in conscious, unrestrained mice by barometric ple-
thysmography, using apparatus and software from Buxco Elec-
tronics. Measurements were performed by standard methods us-
ing this apparatus similarly to that described previously (22). Each
mouse was placed in a chamber and exposed to an aerosol of PBS
(baseline readings) and then increasing concentrations of aero-
solized 
 
b
 
-methacholine (2.5–20 mg/ml; Sigma-Aldrich) for 3
min each. AHR is assessed using the parameter Penh (enhanced
pause), which is calculated automatically based on the mean pres-
sure generated in plethysmograph chambers during inspiration
and expiration, combined with the time of each phase. Penh
readings were taken for 5 min after each aerosol exposure and av-
eraged. Values are represented as the mean percent change in
Penh at each methacholine concentration compared with baseline
readings, calculated from groups of four mice.
 
Characterization of Lung Histology and Cellular Infiltrates.
 
After
AHR measurement, mice were anesthetized and the trachea can-
nulated. Bronchoalveolar lavage (BAL) was performed with 1 ml
0.9% NaCl (Baxter) and the fluid centrifuged at 400 
 
g
 
 to separate
cells from liquid. Fluid was used to determine lung cytokine con-
tent. The total number of BAL cells was determined by trypan
blue exclusion, and then differential cell counts for eosinophils,
neutrophils, lymphocytes, and monocytes were assessed by stain-
ing cytospins with Hema 3 stain (Fisher Scientific), a modified
Wright-Giemsa stain.
Lungs were removed from mice that were not subjected to the
bronchial lavage procedure. Samples were formalin fixed over-
night, stored in 70% ethanol, and sectioned to 5 
 
m
 
m. Sections
were stained with periodic acid-Schiff (PAS) as a measure of mu-
cus production.
 
Cytokine Assays.
 
BAL fluid was assessed for cytokine content
by standard ELISA protocols as described previously (19) using
commercially available antibodies or those produced in house. An-
tibodies 11B11 and biotin-BVD6 (BD PharMingen) were used for
IL-4, TRFK5, and biotin-TRFK4 for IL-5, R46A-2, and biotin-
XMG1.2 (BD PharMingen) for IFN-
 
g
 
. Standard curves were
constructed with purified IL-4, IL-5, and IFN-
 
g
 
 (supernatants
from the respective X63.Ag cell lines). The sensitivity of each assay
was similar, with levels of detection being 50–100 pg/ml.
 
IgE Assay.
 
Mice were bled at the time of killing, after mea-
surement of AHR. Total IgE was quantitated by ELISA using rab-
bit anti-IgE, rat anti-IgE, and horseradish peroxidase–conjugated
rat anti-IgE as described previously (23). OVA-specific IgE was de-
termined in standard ELISAs by first coating plates with OVA, fol-
lowed by the secondary anti-IgE antibody. Values were converted
to arbitrary units using sera from immunized mice as the standard.
 
Results and Discussion
 
The role of OX40 in the allergic inflammatory response
in the lung was determined in the murine model of asthma,
which is induced by sensitization with the protein OVA. 
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Wt and OX40 knockout (
 
2
 
/
 
2
 
) animals were primed for 4
wk and then challenged once a day for 4 d with aerosolized
OVA. This protocol produces a classic asthmatic reaction
characterized by high levels of IgE, Th2 cytokine produc-
tion, eosinophil infiltration in the lungs, mucus production,
and development of AHR.
After the last aerosol exposure, the lungs were lavaged
and the BAL fluid assessed for the presence of cellular infil-
trates by differential cell counting. Control mice that were
not rechallenged with OVA had no inflammatory response
including the absence of cell infiltrates (data not shown).
Wt mice challenged with OVA had three to four times the
number of total cells in the BAL fluid compared with
OX40-deficient mice challenged with OVA (Fig. 1, left).
The predominant infiltrate in Wt mice were eosinophils as
demonstrated many times before in this model, with lower
numbers of neutrophils and lymphocytes (Fig. 1, right). In
striking contrast, the number of eosinophils in the BAL of
OX40-deficient animals was dramatically lower, as was the
number of lymphocytes, whereas fairly equivalent numbers
of neutrophils and monocytes were detected.
There is abundant evidence from many studies that IL-4
plays a major role in development of Th2 cells and induc-
tion of the antibody IgE, but whether IL-4 is an important
effector molecule in many disease scenarios is largely un-
known. In the case of asthma, there is some evidence that
IL-4 is involved in the influx of eosinophils (24–26), al-
though this has not been reproducibly seen. In contrast,
studies of IL-5–deficient animals and T cells have repeat-
edly shown a major role for this cytokine in eosinophilia
(2). To determine the role of OX40 in cytokine produc-
tion in the lungs, BAL fluid was assessed for the presence of
IL-4 and IL-5. In both cases, reduced production was seen
in OX40-deficient animals compared with Wt controls
(Fig. 2 a), with the predominant effect being on IL-5,
which was reduced by 60–70%, directly correlating with
the reduction in eosinophil numbers. As an independent
assessment of the role of OX40 in development of the Th2
response, serum levels of IgE were determined (Fig. 2 b).
Figure 1. Reduced eosinophilia is associated with allergic inflamma-
tion in OX40-deficient mice. Groups of Wt mice (black bars) and
OX402/2 mice (white bars) were immunized with 20 mg OVA given in-
traperitoneally in alum. After 4 wk, each mouse was subjected to an aero-
sol of 5 mg/ml OVA for 30 min for four consecutive days. Approxi-
mately 7 h after the last aerosol, BALs were performed with 1 ml of PBS.
The resultant fluid was analyzed for total cell numbers (left) and for num-
bers of neutrophils (neut), eosinophils (eosin), monocytes (mono), and
lymphocytes (lym) by differential cell counting (right). Results are the
mean number of cells 6 SEM from four separate experiments with four
mice per group in each experiment.
Figure 2. OX40-deficient mice are
impaired in development of allergic Th2
responses. Wt and OX402/2 mice were
immunized and challenged as in the leg-
end to Fig. 1. (a) BAL fluid was assessed
for IL-5 and IL-4 levels by ELISA. (b)
Sera from the mice were analyzed for
OVA-specific IgE levels by ELISA.
Similar data were obtained when mea-
suring total IgE levels (not shown). Re-
sults are the mean levels 6 SEM from
four separate experiments with four
mice per group in each experiment.
Figure 3. AHR and mucus production is reduced in the absence of
OX40. Wt and OX402/2 mice were immunized and challenged as in
Fig. 1. (a) 1–3 h after the last aerosol challenge, individual mice were as-
sessed for AHR as described in Materials and Methods. Results are the
mean percent change 6 SEM in Penh levels above baseline, after expo-
sure to graded doses of methacholine. Values are calculated from four ex-
periments with four mice in each group per experiment. (b) 7 h after the
last aerosol challenge, lungs were removed from mice that were not lav-
aged. Sections were fixed and stained with PAS. Mucus production was
assessed by determining the percentage of goblet cells that stained
strongly. Lung sections from four mice in each group were counted with
at least 1,000 goblet cells analyzed per section, which comprised 70% or
more of the total section. Results are the mean percentage of positive
cells 6 SEM from the four mice. 
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Although the role of IgE in the asthmatic response is con-
troversial (27), there is nonetheless a direct correlation be-
tween Th2 responses, allergic inflammation, and the pro-
duction of this antibody (23). As with the reduction in Th2
cytokines, OVA-specific IgE (and total IgE; not shown) in
OVA-challenged mice lacking OX40 was 
 
,
 
50% of that
induced in Wt mice. Thus, OX40 plays a major role in the
development of the Th2 response that is seen locally in the
lung and also systemically.
The hallmark of allergic inflammation in the lungs is en-
hanced airway reactivity brought about by a combination
of cellular infiltration, goblet cell hyperplasia in the bron-
chiole linings, and overproduction of mucus. To determine
if the lack of OX40 resulted in suppressed AHR, mice
were exposed to 
 
b
 
-methacholine in aerosol form and sub-
jected to analysis with a plethysmograph to determine
Penh. Wt mice exhibited pronounced AHR increasing
over a range of methacholine concentrations. In contrast,
OX40-deficient animals were markedly less responsiveness
at the low concentrations, although they were still capable
of mounting an enhanced response when exposed to a high
dose of methacholine (Fig. 3 a).
The lungs from sensitized and challenged mice were re-
moved immediately after testing for AHR and examined
histologically by staining for cellular architecture around
the bronchioles and for mucus production with PAS base.
 
As seen in Fig. 4, whereas Wt mice had prominent cellular
infiltration around the bronchioles, there was substantially
less in the OX40-deficient mice, correlating with the re-
duced numbers of cells, particularly eosinophils, seen in the
BAL fluid. Additionally, the extent of hyperplasia of the
goblet cells was significantly lower in the absence of
OX40, although compared with a mouse that was not
challenged with antigen (not shown), some inflammation
was still evident. A characteristic feature of asthma patho-
physiology is mucus overproduction in the goblet cells and
the appearance of mucus plugs within the bronchioles (3).
There was a dramatic difference in mucus production,
with 
 
z
 
40% of goblet cells staining strongly with PAS in
Wt mice but only 
 
z
 
5% staining strongly in OX40
 
2
 
/
 
2
 
 ani-
mals (Figs. 3 b and 4). Additionally, mucus plugs within
the bronchioles were common in lungs from Wt mice,
whereas few were detectable in lungs from OX40 knock-
out mice (Fig. 4).
Collectively, these data demonstrate that OX40/OX40L
interactions are integral to development of the asthmatic
phenotype in the murine model used here and complement
previous data that have shown a role for OX40 in generat-
ing T cell responses in several disease scenarios. Initial work
on OX40 suggested that this molecule may preferentially
regulate Th2 responses and suppress development of Th1
responses (15). The demonstration that 
 
L. major
 
–induced
Figure 4. Lung inflammatory infiltrates, goblet
cell hyperplasia, and mucus production are reduced
in OX40-deficient animals. Wt and OX402/2
mice were immunized and challenged with OVA
as in the legend to Fig. 1, and lungs sectioned from
mice that did not undergo BAL. Sections were
stained with PAS. Original magnifications: Top,
310; middle, 320; bottom, 340. Note that dark
areas that are not nuclei represent mucus. Promi-
nent mucus plugs and mucus positive goblet cells
are visible in Wt bronchioles in the middle and
bottom pictures. 
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inflammation in BALB/c mice was inhibited with a block-
ing reagent to OX40L supported this idea (20), particularly
when coupled with studies that suggested that protective
Th1 responses to 
 
Leishmania
 
 in BL/6 mice did not involve
OX40 (20, 21). In contrast, other studies of the helminth
parasite 
 
N. brasiliensis
 
 showed that OX40 was not absolutely
necessary for development of a Th2 response (21), and sub-
sequent studies from ourselves and others have shown that
OX40 can be equally involved in priming for Th1 cyto-
kines in many instances (16, 17, 19). In the study here, the
lack of the asthmatic phenotype in OX40
 
2
 
/
 
2
 
 mice could
have been brought about by defective priming of Th2 cells,
and/or by enhancement of Th1 cytokines that could di-
rectly antagonize Th2 associated pathology (28). Because
we found no evidence for elevated levels of IFN-
 
g
 
 in BAL
samples (data not shown), and both IL-5 and IL-4 produc-
tion were reduced (Fig. 2), this argues against default devel-
opment of Th1 cells when OX40 signals are absent.
In summary, the data in this paper conclusively show
that OX40 ligation is integral to full development of aller-
gic asthma in mice and adds to the growing list of responses
that are controlled by OX40. Earlier reports that CD28/B7
interactions are also involved in allergic asthma (7–9) com-
plement basic studies of T cell responses which have sug-
gested that activation, expansion, and effector function are
controlled by the synergistic action of multiple costimula-
tory receptors (for reviews, see references 12 and 13). We
have proposed that OX40 functions to regulate the number
of T cells that persist over time (19), with OX40 poten-
tially acting both in synergy with CD28 and independently
(14, 29). In contrast, the predominant action of CD28 is to
control the number of T cells that are initially generated
(30), and because of its constitutive expression, CD28 ob-
viously provides signals earlier than OX40, which has to be
induced. Blocking one interaction in isolation has proved
effective in suppressing development of the allergic inflam-
matory response, but significantly, none of the studies of
CD28/B7 or our study here with OX40 have completely
prevented all of the asthmatic symptoms. Therapies which
use a combination approach to target CD28 and OX40 to-
gether may prove effective in completely preventing the
development of allergen-specific T cells.
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